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Evaluation of recombinant adenovirus-
mediated gene delivery for expression of 
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Abstract: Selective labeling of small populations of neurons of a given phenotype for conventional neuronal tracing is diffi   cult 
because tracers can be taken up by all neurons at the injection site, resulting in nonspecifi  c labeling of unrelated pathways. 
To overcome these problems, genetic approaches have been developed that introduce tracer proteins as transgenes under the 
control of cell-type-specifi  c promoter elements for visualization of specifi  c neuronal pathways. Th   e aim of this study was to 
explore the use of tracer gene expression for neuroanatomical tracing to chart the complex interconnections of the central 
nervous system. Genetic tracing methods allow for expression of tracer molecules using cell-type-specific promoters to 
facilitate neuronal tracing. In this study, the rat tyrosine hydroxylase (TH) promoter and an adenoviral delivery system were 
used to express tracers specifi  cally in dopaminergic and noradrenergic neurons. Region-specifi  c expression of the transgenes 
was then analyzed. Initially, we characterized cell-type-specifi  c expression of GFP or RFP in cultured cell lines. We then injected 
an adenovirus carrying the tracer transgene into several brain regions using a stereotaxic apparatus. Th   ree days aft  er injection, 
strong GFP expression was observed in the injected site of the brain. RFP and WGA were expressed in a cell-type-specific 
manner in the cerebellum, locus coeruleus, and ventral tegmental regions. Our results demonstrate that selective tracing of 
catecholaminergic neuronal circuits is possible in the rat brain using the TH promoter and adenoviral expression.
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the brain for information processing.
Dopaminergic neurons play a profound role in diverse 
brain functions, including movement, mood, attention, 
and visceral functions. In the ventral midbrain, dopamine 
is synthesized in the ventral tegmental area (VTA) and 
substantia nigra (SN) (Prakash & Wurst, 2006). The locus 
coeruleus (LC) is the most important noradrenaline-
synthesizing cell group in the brain. This region provides 
widespread and divergent axonal innervation to all regions 
controlling behavioral and sensorimotor responses to external 
stimuli, including the cerebral cortex, striatum, hippocampus, 
thalamus, cerebellum, and the nuclei of the brainstem and 
spinal cord. 
Conventional neuroanatomical tracing methods utilize axonal 
transport of tracers, such as horseradish peroxidase or wheat 
Introduction
The mammalian brain consists of billions of neurons, 
including thousands of cell types that are connected into 
circuits by trillions of synapses. Detailed knowledge of 
neuronal connectivity patterns is indispensible for studies 
of various aspects of brain function. The wiring patterns 
found among various types of neurons via specific synaptic 
connections are the basis of the functional logic employed by Anat Cell Biol 43:157~164, 2010 Mi-La Kim, et al 158
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germ agglutinin (WGA), via neuronal microtubule systems, 
followed by detection of tracers using immunohistochemical 
methods (KÖbbert et al., 2000). WGA is a plant lectin that has 
been used as a highly sensitive tracer for neuroanatomical and 
neuronal mapping studies (Gonatas et al., 1979; Broadwell & 
Balin, 1985; Fabian & Coulter, 1985; Itaya 1987). Th  e  WGA 
protein is a small 18-kD cysteine-rich lectin that binds to 
N-acetylglucosamine and sialic acid carbohydrate moieties 
found on glycoproteins and glycolipids. Because these WGA 
receptors are commonly expressed on the plasma membrane 
surface of most types of neurons in the central nervous 
system, WGA has been used as an eff  ective tracer for a variety 
of neural pathways. WGA is effi   ciently taken up into neurons 
by endocytosis and is transported to axons and dendrites in 
both the anterograde and retrograde directions. Injection 
of WGA in well-mapped neural pathways has shown that 
labeling occurs in both fi  rst- and second-order neurons and 
their processes, indicating that WGA is trans-neuronally 
transported.
Selective labeling of small neuronal populations of a given 
phenotype is difficult using conventional methods because 
the tracers must be delivered by microinjection or local 
application. Th   ese delivery methods allow tracers to be taken 
up by all neurons at the injection site, resulting in nonspecifi  c 
labeling of unrelated pathways. To overcome these problems, 
novel genetic approaches for visualization of specific trans-
synaptic neuronal pathways have been developed that 
introduce a cDNA encoding a transsynaptic protein, such as 
WGA or the nontoxic tetanus toxin C-fragment (TTC), as 
a transgene under the control of cell-type specifi  c promoter 
elements (Yoshihara et al., 1999; Oh et al., 2009). Th  is  genetic 
tracing method allows selective expression of tracers in specifi  c 
neurons using cell-type specific promoters. Therefore, the 
selection of relevant cell-type specifi  c promoters is critical for 
precise neuronal circuit mapping studies using this method. 
To date, the precise afferent and efferent connections of the 
VTA and LC have not been well characterized. Therefore, 
we analyzed the cell-type specifi  city of transgene expression 
under control of the TH promoter in the midbrain region. 
Materials and Methods
Experimental animals
Twelve adult male Sprague-Dawley rats (280~300 g; 
OrientBio, Seongnam, Korea) were used in this study. Animal 
maintenance and treatment were carried out in accordance 
with the Principles of Laboratory Animal Care (NIH 
publication number 85-23, revised 1985) and the Animal 
Care and Use guidelines of Kyung Hee University, Seoul, 
South Korea. Animals were housed at an ambient temperature 
of 18~23
o and at a relative humidity of 10~60% under a 12-h 
light-dark cycle. Animals were allowed free access to water 
and food.
Recombinant adenovirus construction
We used pAdeasy system for recombination of Adenovirus 
gene (He et al., 1998). A gene cassette containing the WGA 
or red fluorescent protein (RFP) cDNA under control of 
the TH promoter was inserted into the pAdTrack plasmid, 
followed by insertion into pAdEasy1 (Fig. 1A). Recombinant 
adenoviral DNA (10 μg) was digested with PacI and 
transfected into HEK293 human embryonic kidney cells in a 
10-cm dish using Lipofectamine (Invitrogen, Carlsbad, CA). 
Viruses were harvested from transfected HEK293 cells 5 days 
after transfection and were amplified one time in HEK293 
cells in ten 15-cm dishes. Viral particles were purified by 
cesium chloride density gradient ultracentrifugation and 
dialyzed against a viral storage solution (10 mM Tris, pH 
7.4; 135 mM NaCl; 1 mM MgCl2; 5% sucrose). Viral stocks 
were titered using the end-point dilution method. Cell-type 
specifi  city of the TH promoter was then analyzed. Cell-type-
specific expression of GFP and RFP was observed under a 
fl  uorescent microscope.
Stereotaxic injection of the adenoviral vector and 
brain section preparation
Adenovirus (1.5 μl of a 3×10
11-EFU/ml solution) was 
unilaterally injected into the rat LC (AP: 9.8 mm relative to 
bregma, L: ＋1.3 mm from the midline, and DV: －6.5 mm 
below the dura), VTA (AP: －4.7 mm relative to bregma, L: ＋
1.6 mm from the midline, and DV: －8.0 mm below the dura) 
or cerebellum (AP: －9.9 mm relative to bregma, L: ＋1.2 mm 
from the midline, and DV: －5.5 mm below the dura). We 
injected adenovirus on site of LC and VTA. But, we injected 
continuously through withdrawal of needle for cerebellum 
injection. Three days after stereotaxic injection, rats were 
anesthetized with pentobarbital sodium (60 mg/kg, i.p.) and 
perfused transcardially with 4% paraformaldehyde in 0.1M 
phosphate buff  er, pH 7.4. Brains were isolated and post-fi  xed 
in the same fi  xative overnight. Th   e brains were subsequently 
cryoprotected with 30% sucrose in 0.05M phosphate-buff  ered Adenovirus-mediated tracer gene expression
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saline (PBS, pH 7.4) for 48 h and sectioned coronally into 40-
μm sections for histological analyses. 
Immunohistochemistry and immunofl  uorescence
Aft  er three washes with PBS each for 5 min, sections were 
processed for the immunohistochemical detection of WGA 
using goat polyclonal anti-WGA antibody (1 : 2,000; Vector, 
Burlingame, CA). Free-floating sections were incubated for 
48 h in PBS (4
oC) containing anti-WGA antibodies (1 : 2,000), 
0.3% (v/v) Triton X-100, 0.05% (w/v) bovine serum albumin, 
and 1.5% (v/v) normal horse serum. Using the Vectastain-
Elite kit (Vector, Burlingame, CA), we incubated sections 
with horse anti-goat secondary antibodies (1 : 100) for 90 min 
and with avidin-biotin-peroxidase complex (1 : 100) for 1 h 
at room temperature. The sections were reacted with 0.02% 
(w/v) 3,3’diaminobenzidine tetrahydrochloride and 0.01% 
(v/v) H2O2 for about 3 min. Following incubation, sections 
were washed three times in PBS, for a total wash time of 15 
min. Sections were dehydrated with alcohol and xylene and 
mounted with Permount solution. Images were captured 
using an Axioscope and Axiocam CCD camera (Zeiss, Ober 
Kochen, Germany).
For immunofluorescence staining, brain sections were 
incubated with goat anti-WGA antibodies (1 : 2,000) at 4
oC 
for 12~15 h, then we washed sections with PBS for 15 min, 
followed by incubation with biotinylated horse anti-goat 
IgG (1 : 200; Vector) for 1.5 h. Sections were then incubated 
1 h with streptavidin-rhodamine or strepatavidin-FITC (1 : 
200; Vector). Hoechst 33342 incubation for 3 min was used 
to visualize nuclei. Slides were mounted using Vectashield 
mounting medium (Vector). Fluorescent images were cap-
tured using a confocal microscope (LSM 510-META, Zeiss).
Fig. 1. Structure and recombinant 
adenovirus transfection in cultured cells 
and cerebellar injections in Sprague-
Dawley rats. (A) Cell type specific 
promoter and tracer transgene of 
recombinant adenovirus. (B) HEK293 
cells were cultured in 10-cm culture 
dishes. (C) Five days after transfection 
with the pAdeasy-TH-RFP-CMV-GFP 
construct, strong GFP expression was 
observed in HEK293 cells. (D) Three 
days after injection of the TH-RFP-
CMV-GFP recombinant adenovirus 
into the cerebellum of male Sprague-
Dawley rats, GFP was highly expressed 
in the cerebellar cortex. g, granular 
layer; P, Purkinje cell layer; m, molecular 
layer; (E) RFP was not expressed in the 
cerebellar cortex. Scale bars=100 μm. Anat Cell Biol 43:157~164, 2010 Mi-La Kim, et al 160
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Results
Cell type specifi  c expression of transgene
A recombinant adenovirus (pAdeasy-TH-RFP-CMV-GFP) 
that expresses the RFP gene under control of the cell-type-
specifi  c TH promoter and the GFP gene under control of the 
general CMV promoter was tested in HEK293 cells. Five days 
after transfection with pAdeasy-TH-RFP-CMV-GFP, strong 
GFP expression was observed in HEK293 cells, but RFP was 
not expressed, consistent with expected results. We next 
injected the TH-RFP-CMV-GFP recombinant adenovirus 
into the cerebellum of adult male Sprague-Dawley rats. Th  ree 
days after injection with the recombinant adenovirus, GFP 
was highly expressed in the cerebellar cortex. Adenovirus can 
infect all phenotype of cells, including neurons and glia. CMV 
promoter can induce GFP expression in all infected cells. 
Th   erefore, GFP positive cells are Prukinje cells, granule cells 
and glia. In contrast, RFP was not expressed in the injected 
side of the cerebellum (Fig. 1).
Th   e TH-RFP-CMV-GFP recombinant adenovirus was next 
injected into the LC of adult rats. Th   ree days aft  er injection, 
strong GFP expression was observed in the injected side of 
the midbrain. In addition, RFP was also highly expressed in 
several neurons of the LC. Th   e merged image shows that RFP 
colocalized with GFP in the same neurons (Fig. 2).
Tracer gene expression in specifi  c brain regions
We also tested a cell-type-specific WGA-expressing 
recombinant adenovirus (TH-WGA-CMV-GFP) by injection 
into the VTA of male Sprague-Dawley rats. Th   ree days aft  er 
recombinant adenovirus injection, GFP was highly expressed 
at the site of injection. Furthermore, immunohistochemical 
staining for WGA demonstrated the presence of WGA-
immunoreactive cells in regions adjacent to the injected site 
(Fig. 3).
The WGA-expressing recombinant adenovirus was also 
injected into the LC of male Sprague-Dawley rats. GFP was 
highly expressed in the injected side of the LC and in adjacent 
regions. Some GFP-positive fibers were distributed in the 
lower lateral side of the midbrain. Immunofl  ourescent staining 
for WGA showed several WGA-positive (red) neurons that 
Fig. 2. Transgene expression 3 days after injection of the TH-RFP-
CMV-GFP recombinant adenovirus into the locus coeruleus. (A) 
Distribution of Hoechst 33342-stained nuclei in the midbrain. (B) 
GFP was highly expressed in the injected side of midbrain. (C) RFP 
was expressed in several neurons of the LC. (D) RFP expression 
colocalized with GFP-positive neurons. Scale bar=100 μm.
Fig. 3. Transgene expression 3 days aft  er 
TH-WGA-CMV-GFP recombinant 
adenovirus injection into the VTA. 
(A) GFP was highly expressed in the 
injected side. (B) Magnified image of 
the indicated region of (A) (square). (C) 
WGA immunohistochemistry showed 
the presence of WGA-immunoreactive 
neurons in regions adjacent to the 
injected site. Scale bar=100 μm. Adenovirus-mediated tracer gene expression
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colocalized with GFP fluorescence. Immunohistochemical 
staining for WGA using DAB solution showed the presence 
of WGA-immunoreactive neurons in the injected side of 
the LC. The contralateral side of the LC showed no WGA-
immunoreactive neurons (Fig. 4). In order to confirm the 
colocalization of WGA with GFP, we captured Z-stack images 
3 days after TH-WGA-CMV-GFP recombinant adenovirus 
injection into the VTA. GFP was highly expressed in the 
injected side of the VTA. Many GFP-positive fibers were 
distributed among the GFP-positive cell bodies. WGA 
immunohistochemistry revealed the presence of several red 
fluorescent WGA-positive neurons. WGA-positive fibers 
and cell bodies were distributed in adjacent regions. Z-stack 
images showed that WGA colocalized with GFP in the VTA 
(Fig. 5). 
Discussion
Th   e CNS is composed of billions of neurons interconnected 
to form intricate neuronal circuits (Boldogkoi et al., 2004; 
Livet et al., 2007). Neuronal tracing has been used to identify 
and characterize neuronal pathways and functions in specifi  c 
neuronal circuits of the complex nervous system (Yoshihara 
2002). Gene promoter systems that drive high-level, cell-
type-specifi  c tracer gene expression are of great value because 
they allow specifi  c cell types to endogenously express tracers, 
leading to visualization of specific neural circuitry of the 
brain. Once the tracer gene has been delivered to the target 
neuron, expression level and specifi  city is dependent upon the 
activity of the promoter elements incorporated into the vector 
used for gene delivery.
Previously, several nonspecifi  c promoters have been used 
for gene delivery. Th   e CMV promoter has been widely used 
Fig. 4. Transgene expression 3 days after TH-WGA-CMV-GFP recombinant adenovirus injection into the LC. (A) Distribution of Hoechst 
33342-positive nuclei in the midbrain. (B) GFP was highly expressed in the injected side of the LC and in adjacent regions. Some GFP-positive 
fi  bers were distributed in the lower lateral side of midbrain. (C) WGA immunohistochemistry showed that several neurons were positive for WGA 
staining. (D) Merged image of (A, B) and (C). (E~H) Magnifi  ed images of the indicated region of (D) (square). (E) Distribution of Hoechst 
33342 stained nuclei. (F) GFP-expressing cells. (G) WGA-immunoreactive neurons. (H) Merged image. (I) WGA immunohistochemistry using 
DAB development showed WGA-immunoreactive neurons in the injected side of the locus coeruleus. (J) Contralateral side of the locus coeruleus. 
(K) Magnifi  ed image of the indicated region of (I) (square). (L) Magnifi  ed image of the indicated region of (J) (square). Scale bar=100 μm.  Anat Cell Biol 43:157~164, 2010 Mi-La Kim, et al 162
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to drive expression of various transgenes. Kissa et al. used 
the CMV promoter in an adenoviral vector for delivery of 
the GFP-TTC gene for in vivo neuronal tracing (Kissa et 
al., 2002). The CMV immediate enhancer/β-actin (CAG) 
promoter was shown to promote higher levels of transgene 
expression in several cell lines compared with the CMV and 
β-actin promoters (Niwa et al., 1991). Infusion of a WGA-
expressing adenovirus under control of the CAG promoter 
through mouse nostrils led to infection and WGA expression 
in various cell types throughout the olfactory epithelium 
(Kinoshita et al.,  2002). Other promoters, such as the NSE 
promoter (Navarro et al., 1999), synapsin-1 promoter (Kügler 
et al., 2001), and the human PDGF β-chain promoter, have 
been combined with the CMV promoter (Liu et al., 2004) to 
promote neuronal expression of transgenes. Th  ese  promoters 
are useful for robust expression of tracers in the target regions, 
but their utility is limited due to a lack of specifi  city. Recently, 
Livet et al. (2007) generated thy-1-brainbow mice lines, in 
which most mice exhibited coexpression of multiple colors in 
individual cells in the brain.
We previously developed a synthetic promoter driving 
transgene expression in catecholaminergic neurons (Oh et 
al., 2009). In order to trace the neuronal circuit of midbrain 
dopaminergic neurons, we sought to use the TH upstream 
promoter. Toward this goal, we investigated the use of the 
2.5 kb rat TH upstream promoter as a dopaminergic neuron 
specifi  c promoter.
In this study, we observed cell-type-specifi  c expression of a 
transgene in vitro and in vivo. In cultured HEK293 cells, GFP 
was highly expressed under control of the CMV promoter. 
However, RFP, under control of the cell-type-specific TH 
promoter, was not expressed in HEK293 cells. The CMV 
promoter can drive expression of various transgenes in most 
cells; therefore, GFP was strongly expressed in HEK293 
cells, a human embryonic kidney cell line. In contrast, the 
TH promoter, a neuron-specific promoter, did not promote 
RFP expression in the kidney cell line. Injection of the TH-
RFP-CMV-GFP recombinant adenovirus into the cerebellum 
of male Sprague-Dawley rats resulted in strong expression 
of GFP. However, RFP, under the control of TH promoter, 
was not expressed. These results suggest that the TH 
promoter drives highly specific expression of the transgene. 
Catecholaminergic neurons are not found in the cerebellum; 
therefore, RFP was not expressed in the cerebellar cortex. 
In contrast to the cerebellum, we observed strong 
expression of RFP in the LC of adenovirus-injected mice. 
The LC is the primary source of noradrenergic output in 
the brain. Noradrenergic neurons express the TH enzyme 
for synthesis of noradrenaline. Therefore, RFP under the 
control of TH promoter was highly expressed in the LC. We 
also observed expression of WGA in the VTA and LC after 
Fig. 5. Transgene expression 3 days after TH-WGA-CMV-GFP 
recombinant adenovirus injection in the VTA. (A) Distribution of 
Hoechst 33342-positive nuclei in the injected side of the VTA. (B) 
GFP was highly expressed in the injected side of the VTA. Many GFP-
positive fibers were distributed among the GFP-positive cell bodies. 
(C) WGA immunohistochemistry showed that several neurons were 
WGA positive. WGA-positive fi  bers and cell bodies were distributed in 
adjacent regions. (D) Merged image of (A, B) and (C). Z-stack image 
of (E) GFP and WGA colocalized in the same cells. Scale bar=100 μm. Adenovirus-mediated tracer gene expression
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injection of a recombinant adenovirus that expressed this 
transgene under control of the TH promoter. These regions 
have many dopaminergic and noradrenergic neurons, 
leading to high expression of WGA under control of the TH 
promoter. Recently, Oh et al. (2009) used the 2.5-kb rat TH 
promoter in adenovirus or adeno-associated virus (AAV) 
to express tracers specifi  cally in dopaminergic neurons. Th  e 
TH promoter has previously been shown to drive cell-type-
specifi  c gene expression in midbrain dopaminergic neurons 
using transgenic founder analysis (Liu et al., 1997). This 
vector drove prominent transgene expression in dopaminergic 
neurons of the SN. Th   erefore, our fi  ndings are consistent with 
these studies.
Th   e genetic approach using the WGA transgene expressed 
under the control of cell-type-specific promoter elements 
resulted in labeling of neuronal circuits originating from a 
specific type of neuron. Previous studies in transgenic mice 
have used the TTC transgene as a retrograde tracer (Maskos et 
al., 2002). Although the transgenic mouse approach provides 
an effi   cient system to study gene function under a variety of 
physiological and pathological circumstances, this technology 
is rather technically challenging (Hickman-Davis & Davis, 
2006). An alternative and complementary approach is direct 
gene transfer using stereotaxic injection of recombinant viral 
vectors. This approach permits convenient spatio-temporal 
control of transgene expression (Pilpel et al., 2009). Indeed, 
several recent studies have used viral-mediated gene delivery 
for neuronal tracing, demonstrating the eff  ectiveness of this 
technique. Kinoshita et al. visualized olfactory pathways using 
a WGA-expressing adenoviral vector system (Kinoshita et al., 
2002). Th   ey generated a recombinant adenovirus expressing 
WGA under the control of the CAG promoter. Recent studies 
have used cell-type-specific promoters to direct expression 
of GFP-WGA to midbrain dopaminergic neurons and 
central noradrenergic neurons using AAV and adenovirus, 
respectively (Oh et al., 2009). In addition, Wickersham et al. 
used a genetically modified rabies virus for monosynaptic 
restriction of viral transsynaptic tracing (Wickersham et al., 
2007a; Wickersham et al., 2007b). 
In this study, we used the TH promoter for cell-type-
specific expression of a tracer transgene and the CMV 
promoter for non-specific expression of GFP. Under the 
control of the CMV promoter, robust expression of the 
downstream transgene is promoted in most mammalian 
cells, including neurons. Therefore, using this virus, we 
can differentiate between tracer expression in adenovirus-
infected, GFP-expressing cells and that in non-infected cells 
through the combined use of the CMV and TH promoters. 
WGA was has been widely used as a transsynaptic tracer. 
Therefore, adenoviral vectors containing the WGA cDNA 
downstream of neuron-specifi  c promoter elements will likely 
prove useful for restricted expression of WGA in a region- 
and cell-type-specifi  c manner.
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